article thumbnail

Pharma Must Speak Up for Patient Safety

World of DTC Marketing

It’s a basic principle: the healthcare system exists to serve patients. Yet, astonishingly, the very institutions tasked with protecting and managing our healthcare can sometimes become a threat to patient safety. Patient safety and advocacy must take precedence over fears of political or regulatory retribution.

Safety 156
article thumbnail

Pfizer Stops Work on Oral GLP-1 Obesity Drug After Safety Signal Surfaces in Clinical Trial

MedCity News

Pfizer said a patient dosed with danuglipron developed potential drug-induced liver injury. Pfizer is stopping further work on this program, a move that comes nearly two years after it discontinued development of a different obesity drug due to liver safety signals in a clinical trial.

Safety 237
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Connected Care, Shared Goals: Designing Whole-Person Care for Complex Patient Populations

MedCity News

As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. The post Connected Care, Shared Goals: Designing Whole-Person Care for Complex Patient Populations appeared first on MedCity News.

Patients 249
article thumbnail

Patient Safety Structural Measure Marks Progress Towards Safer and Compassionate Care

MedCity News

CMS recently finalized the Patient Safety Structural Measure, which sets forth a broad roadmap for the implementation of a culture of safety, learning, transparency and accountability within hospitals and health systems nationwide — enabling and encouraging significant progress towards safer care and improved support for healthcare workers.

Safety 290
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

'It was a good lesson': FDA reconsiders CAR-T boxed warning on secondary cancers, Peter Marks says

Fierce Pharma

An FDA announcement last year of an investigation into the risk of patients developing secondary cancers following the treatment of CAR-T cell therapies sent shock waves across the industry. | said in an interview with Fierce Pharma.

FDA 338
article thumbnail

No Wrong Door: How Policy, Technology & Partnerships Can Power a Connected Social Safety Net

MedCity News

Through the convergence of proactive policy, advanced technology and strategic public-private partnerships, we can achieve this “no wrong door” vision and deliver a connected, streamlined social safety net that’s more efficient, economical, and effective. Here’s how.

Safety 271